AcelRx Pharma shares sink as FDA rejects its opioid painkiller

(Reuters) – AcelRx Pharmaceuticals Inc’s shares plunged more than 60 percent before the bell on Thursday after the U.S. Food and Drug Administration rejected the drugmaker’s opioid painkiller in its present form.

Powered by WPeMatico

Leave a Reply

Your email address will not be published. Required fields are marked *